Ethyl 6-((2,6-diazaspiro[3.4]octan-6-yl)methyl)-4-(2-bromo-4-fluorophenyl)-2-(thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate

ID: ALA4866011

PubChem CID: 164625005

Max Phase: Preclinical

Molecular Formula: C23H25BrFN5O2S

Molecular Weight: 534.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1=C(CN2CCC3(CNC3)C2)NC(c2nccs2)=NC1c1ccc(F)cc1Br

Standard InChI:  InChI=1S/C23H25BrFN5O2S/c1-2-32-22(31)18-17(10-30-7-5-23(13-30)11-26-12-23)28-20(21-27-6-8-33-21)29-19(18)15-4-3-14(25)9-16(15)24/h3-4,6,8-9,19,26H,2,5,7,10-13H2,1H3,(H,28,29)

Standard InChI Key:  ZWFMJQGSAHXKIW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   21.9324   -7.4377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9283   -8.2549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7455   -8.2590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7496   -7.4418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2320   -4.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2308   -4.9509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9389   -5.3598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6485   -4.9504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6457   -4.1277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9371   -3.7225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5242   -3.7229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5240   -2.9057    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8165   -4.1317    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1087   -3.7232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4011   -4.1320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5228   -5.3589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5221   -6.1761    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9318   -2.9081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6399   -2.4980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6378   -1.6816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9284   -1.2743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2196   -1.6894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2251   -2.5044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3574   -5.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4441   -6.1680    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   25.2437   -6.3367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6512   -5.6283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1034   -5.0219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3484   -2.9052    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   22.9249   -0.4571    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.8606   -6.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1125   -7.4357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1828   -6.6593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  1  0
  5 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
  6 16  1  0
 16 17  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 10 18  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  2  0
  8 24  1  0
 19 29  1  0
 21 30  1  0
 17 31  1  0
 31 32  1  0
 32  1  1  0
  1 33  1  0
 33 17  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4866011

    ---

Associated Targets(non-human)

HBcAg Core antigen (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 534.45Molecular Weight (Monoisotopic): 533.0896AlogP: 3.25#Rotatable Bonds: 6
Polar Surface Area: 78.85Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.00CX LogP: 2.59CX LogD: 0.08
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.55Np Likeness Score: -1.24

References

1. Ma Y, Zhao S, Ren Y, Cherukupalli S, Li Q, Woodson ME, Bradley DP, Tavis JE, Liu X, Zhan P..  (2021)  Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors.,  225  [PMID:34438123] [10.1016/j.ejmech.2021.113780]

Source